ArticleOncogene2025

Therapeutic targeting of the p300/CBP bromodomain enhances the efficacy of immune checkpoint blockade therapy.

Jinghui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.